Inventor · disambiguated record
Venkitasamy Kesavan
Also filed as: KESAVAN VENKITASAMY
15 granted patents·6 pending applications·568 citations·filing 2003–2022
94Inventor score
Files withALNYLAM PHARMACEUTICALS INC11DHANOA DALE S3MANOHARAN MUTHIAH3ALNYLAM PHARMACEUTICALS1EPIX DELAWARE INC1
Top patents by PatentIndex Score
21 records- 0198US8404862B2Ligand-conjugated monomersMANOHARAN MUTHIAH·Filed 2009·Granted Mar 26, 2013·84 cites·40 claims
- 0298US7745608B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2004·Granted Jun 29, 2010·129 cites·43 claims
- 0398US7582744B2Chemically modified oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted Sep 1, 2009·177 cites·23 claims
- 0496US8507661B2Modified iRNA agentsMANOHARAN MUTHIAH·Filed 2010·Granted Aug 13, 2013·25 cites·48 claims
- 0596US8017763B2Chemically modified oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Sep 13, 2011·31 cites·27 claims
- 0696US7626014B2Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moietyALNYLAM PHARMACEUTICALS·Filed 2005·Granted Dec 1, 2009·53 cites·64 claims
- 0795US8796436B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·14 cites·23 claims
- 0889US8957223B2Ligand-conjugated monomersALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Feb 17, 2015·9 cites·28 claims
- 0988US11312957B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Apr 26, 2022·1 cites·20 claims
- 1084US10676740B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Jun 9, 2020·1 cites·13 claims
- 1183US9453222B2Ligand-conjugated monomersALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Sep 27, 2016·4 cites·21 claims
- 1283US7030240B2Piperidinylamino-thieno[2,3-d] pyrimidine compoundsPREDIX PHARMACEUTICALS HOLDING·Filed 2004·Granted Apr 18, 2006·34 cites·22 claims
- 1380US8470988B2Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moietyMANOHARAN MUTHIAH·Filed 2009·Granted Jun 25, 2013·3 cites·30 claims
- 1480US2022403377A1MODIFIED iRNA AGENTSALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1579US9394540B2Modified iRNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jul 19, 2016·1 cites·17 claims
- 1674US7612078B2Piperidinylamino-thieno[2,3-D] pyrimidine compoundsEPIX DELAWARE INC·Filed 2005·Granted Nov 3, 2009·2 cites·16 claims
- 1762US2016264968A1MODIFIED iRNA AGENTSALNYLAM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1858US2010113485A1Piperidinylamino-thieno[2,3-D] Pyrimidine CompoundsDHANOA DALE S·Filed 2009·Application pending·0 cites
- 1950US2005222175A1New piperidinylamino-thieno[2,3-D] pyrimidine compoundsDHANOA DALE S·Filed 2004·Application pending·0 cites
- 2040US2011082157A1Piperidinylamino-Thieno [2,3-D] Pyrimidine CompoundsDHANOA DALE S·Filed 2010·Application pending·0 cites
- 2140US2004138238A1Substituted aminopyrimidine compounds as neurokinin antagonistsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Venkitasamy Kesavan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →